Shares of Gilead Sciences Inc. /zigman2/quotes/210293917/composite GILD +0.51% advanced 1.16% to $72.09 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +2.47% falling 0.14% to 4,670.29 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.76% falling 0.45% to 36,068.87. The stock's rise snapped a seven-day losing streak. Gilead Sciences Inc. closed $2.03 below its 52-week high ($74.12), which the company achieved on December 30th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.91% fell 0.49% to $173.09, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.83% rose 2.58% to $82.37, and AbbVie Inc. /zigman2/quotes/202428675/composite ABBV -0.38% rose 1.12% to $136.39. Trading volume (10.3 M) eclipsed its 50-day average volume of 7.2 M.